RhumbLine Advisers’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169 | Sell |
544
-129,156
| -100% | -$40.1K | ﹤0.01% | 4097 |
|
|
2025
Q1 | $63.4K | Sell |
129,700
-4,635
| -3% | -$2.27K | ﹤0.01% | 3520 |
|
|
2024
Q4 | $115K | Buy |
134,335
+988
| +0.7% | +$846 | ﹤0.01% | 3441 |
|
|
2024
Q3 | $1.13M | Sell |
133,347
-548
| -0.4% | -$4.66K | ﹤0.01% | 2199 |
|
|
2024
Q2 | $625K | Buy |
133,895
+133,351
| +24,513% | +$623K | ﹤0.01% | 2513 |
|
|
2024
Q1 | $3.7K | Hold |
544
| – | – | ﹤0.01% | 4019 |
|
|
2023
Q4 | $1.82K | Hold |
544
| – | – | ﹤0.01% | 4105 |
|
|
2023
Q3 | $1.35K | Hold |
544
| – | – | ﹤0.01% | 4156 |
|
|
2023
Q2 | $696 | Buy |
+544
| New | +$696 | ﹤0.01% | 4303 |
|
|
2022
Q2 | – | Sell |
-17,409
| Closed | -$37K | – | 3099 |
|
|
2022
Q1 | $37K | Sell |
17,409
-706
| -4% | -$1.5K | ﹤0.01% | 2987 |
|
|
2021
Q4 | $162K | Sell |
18,115
-321
| -2% | -$2.87K | ﹤0.01% | 2878 |
|
|
2021
Q3 | $306K | Buy |
18,436
+825
| +5% | +$13.7K | ﹤0.01% | 2756 |
|
|
2021
Q2 | $366K | Buy |
17,611
+1,869
| +12% | +$38.8K | ﹤0.01% | 2707 |
|
|
2021
Q1 | $295K | Sell |
15,742
-160
| -1% | -$3K | ﹤0.01% | 2697 |
|
|
2020
Q4 | $350K | Buy |
15,902
+1,000
| +7% | +$22K | ﹤0.01% | 2602 |
|
|
2020
Q3 | $309K | Sell |
14,902
-1,490
| -9% | -$30.9K | ﹤0.01% | 2508 |
|
|
2020
Q2 | $593K | Buy |
16,392
+8,623
| +111% | +$312K | ﹤0.01% | 2270 |
|
|
2020
Q1 | $254K | Buy |
+7,769
| New | +$254K | ﹤0.01% | 2472 |
|